JY
CDIO icon

Jeff Yass’s Cardio Diagnostics CDIO Stock Holding History

Jeff Yass’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,060
Closed -$47K – 12512
2025
Q2 		$47K Buy
+13,060
New +$97.7K ﹤0.01% 12129
2023
Q1 		– Sell
-788
Closed -$26.2K – 12629
2022
Q4 		$26.2K Buy
+788
New +$85.1K ﹤0.01% 11671

Other funds holding CDIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jeff Yass's CDIO Position: Q3 2025 in Review

Jeff Yass sold out of Cardio Diagnostics (CDIO) in Q3 2025, closing a stake of 13,060 shares — an estimated $47K sold.

Jeff Yass first reported a position in CDIO in Q4 2022 and held it in 2 quarters. The position peaked at $47K in Q2 2025. 14 funds tracked by Wall St. Rank hold CDIO as of Q3 2025.

  • Jeff Yass reported no remaining Cardio Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Jeff Yass sold 13,060 Cardio Diagnostics shares in Q3 2025, an estimated $47K.
  • Jeff Yass first reported a position in Cardio Diagnostics in Q4 2022 and held it in 2 quarters.
  • Jeff Yass's Cardio Diagnostics position peaked at $47K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.